- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CYTK
Recent news which mentions CYTK
Tesla Stock 'Could Fall 90% Tomorrow,' Fund Manager Still Won't Buy — Here's Where He's Investing Instead
August 26, 2025
From Benzinga
Earnings Scheduled For August 7, 2025
August 07, 2025
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
May 02, 2025
From Benzinga
Block, Atlassian, Apple, Roku, Amazon And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 02, 2025
From Benzinga
From Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday
April 24, 2025
From Benzinga
Bristol Myers Analyst Says FDA Update Is A Win For Camzyos With Simpler Use, Broader Reach
April 21, 2025
From Benzinga
From Benzinga
From Benzinga
Applied Digital Posts Weak Revenue, Joins Allegro MicroSystems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
April 15, 2025
From Benzinga
Cognyte Software Posts Upbeat Results, Joins AngioDynamics, Allegiant Travel And Other Big Stocks Moving Higher On Wednesday
April 02, 2025
From Benzinga
Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday
March 21, 2025
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
From Benzinga
From Benzinga
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
January 22, 2025
From Benzinga
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
January 22, 2025
From Benzinga
Why Cytokinetics Stock Was a Nearly 5% Winner Today
December 20, 2024
From Motley Fool
This Cytokinetics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
November 08, 2024
From Benzinga
Netflix To $650? Here Are 10 Top Analyst Forecasts For Wednesday
October 09, 2024
From Benzinga
Cytokinetics Sets Stage For Mid-Stage Study For Heart Failure Drug After Encouraging Data From Phase 1 Study
September 09, 2024
From Benzinga
Tickers
CYTK
From InvestorPlace
7 Biotech Stocks to Boost Your Portfolio to Peak Health
June 26, 2024
From InvestorPlace
From InvestorPlace
From Benzinga
Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
May 23, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.